FDA Approved: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC — Original Application (Glenmark Pharmaceuticals Inc.,USA)

View source ↗

Summary

FDA approved Glenmark's pediatric generic combination of atovaquone and proguanil hydrochloride (ANDA) for malaria in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Atovaquone and Proguanil Hydrochloride Pediatric (atovaquone and proguanil hydrochloride)

Snippet

ORIG AP for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC)